Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
Open Access
- 20 February 2007
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 96 (5) , 681-685
- https://doi.org/10.1038/sj.bjc.6603625
Abstract
Tumour-associated changes have been observed in the circulating nucleic acids of cancer patients and have been proposed to be useful for the detection and monitoring of cancers. In this review, different approaches for detecting tumour-associated nucleic acids in the circulation and their potential applications as tumour markers are discussed.Keywords
This publication has 32 references indexed in Scilit:
- The detection of oesophageal adenocarcinoma by serum microsatellite analysisEuropean Journal of Surgical Oncology, 2006
- Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast CancerJournal of Clinical Oncology, 2006
- Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in SerumJournal of Clinical Oncology, 2006
- Quantitative Detection of p53 Mutations in Plasma DNA from Tobacco SmokersCancer Research, 2006
- TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective StudyCancer Research, 2006
- Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective studyAnnals of Oncology, 2006
- Serum Circulating Human mRNA Profiling and Its Utility for Oral Cancer DetectionJournal of Clinical Oncology, 2006
- Reduced Plasma RNA Integrity in Nasopharyngeal Carcinoma PatientsClinical Cancer Research, 2006
- Effects of Preanalytical Factors on the Molecular Size of Cell-Free DNA in BloodClinical Chemistry, 2005
- Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal CarcinomaJNCI Journal of the National Cancer Institute, 2002